Open Access · CC BY-NC 4.0
Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma
World Journal of Oncology · 2026-12 · 17 (6) · 898-911
DOI: 10.14740/wjon2858 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2026-12. Verfasst von Shawnm Abdulah Ismail und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ismail, S. A., & Ismail, P. A. (2026). Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma. World Journal of Oncology, 17(6), 898-911. https://doi.org/10.14740/wjon2858
Vancouver
Ismail SA, Ismail PA. Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma. World Journal of Oncology. 2026;17(6):898-911. doi:10.14740/wjon2858
BibTeX
@article{Ismail2026,
author = {Ismail, Shawnm Abdulah and Ismail, Parween Abdulsamad},
title = {Dysregulated Serum miR-222-3p, miR-595, and miR-130a-3p as Potential Noninvasive Diagnostic Biomarkers for Papillary Thyroid Carcinoma},
journal = {World Journal of Oncology},
year = {2026},
volume = {17},
number = {6},
pages = {898--911},
doi = {10.14740/wjon2858}
}
EUVIMED